ArticleCell reports2025

BCL2 drives castration resistance in castration-sensitive prostate cancer by orchestrating reciprocal crosstalk between oncogenic pathways.

Rahim Hirani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.